Peter Blume-jensen
Oncology
Veritas
United States of America
Biography
Scientific leader in personalized oncology, targeted oncology therapeutics, and biomarker research. Currently CSO Xtuit. Former executive with Metamark Genetics, Daiichi Sankyo, Merck and Serono.
Research Interest
Oncology, Targeted Oncology Therapeutics, and Biomarker Research